4D Molecular Therapeutics, Inc 10-K for FY2024
4D Molecular Therapeutics, Inc. (FDMT)
10-K
2025-02-28
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
4D Molecular Therapeutics, Inc filed this 10-K on February 28, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $37K
- down 99.8% from $20.72M a year earlier
- Net loss
- $160.87M
- compared with a net loss of $100.84M a year earlier
- Diluted EPS
- -$2.98
- compared with -$2.58 a year earlier